Literature DB >> 29095203

Acute Respiratory Distress Syndrome Cases Volume and ICU Mortality in Medical Patients.

Martin Dres1,2,3, Peter C Austin4,5, Tài Pham3,6, Philippe Aegerter7,8, Bertrand Guidet9,10, Alexandre Demoule1,2, Antoine Vieillard-Baron8,11,12, Laurent Brochard3,6, Guillaume Geri8,11,12.   

Abstract

OBJECTIVES: To determine whether ICUs caring for higher volumes of acute respiratory distress syndrome patients would be associated with lower ICU mortality.
DESIGN: A 9-year multicenter retrospective cohort study of prospectively collected data.
SETTING: French medical ICUs. PATIENTS: From 2004 to 2012, acute respiratory distress syndrome cases were identified from a coding system through a regional database (Collège des Utilisateurs de Données en Réanimation).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Volume was calculated as the cumulative annual mean number of acute respiratory distress syndrome cases. Severity (Simplified Acute Physiology Score 2) and ICU mortality between categories (low, medium, and high) of acute respiratory distress syndrome cases volume were analyzed. Multivariable analysis using mixed effects models was performed to adjust for severity of illness and confounding factors. Over the study period, 8,383 acute respiratory distress syndrome patients among 31 ICUs met the study inclusion criteria. Overall, Simplified Acute Physiology Score 2 (median [interquartile]) was 58 (43-74), whereas ICU mortality was 53.7%. Severity as assessed by Simplified Acute Physiology Score 2 (median [interquartile]) was significantly higher in high-volume ICUs (> 65 acute respiratory distress syndrome per year) as compared to low (≤ 29 acute respiratory distress syndrome per year) and medium-volume ICUs (> 29-65 acute respiratory distress syndrome per year): 61 (46-77) versus 55 (41-72) and 55.0 (40-72), respectively (p < 0.01). ICU mortality was similar across the acute respiratory distress syndrome volume categories (53.6%, 54.1%, and 53.3% in low-, medium-, and high-volume categories ICUs, respectively). After adjustment for confounders, acute respiratory distress syndrome case volume was independently associated with ICU mortality (odds ratio for log-transformed volume: 0.77 [95% CI, 0.62-0.96]; p = 0.02).
CONCLUSIONS: ICUs caring for higher volumes of acute respiratory distress syndrome cases were associated with lower ICU mortality.

Entities:  

Mesh:

Year:  2018        PMID: 29095203     DOI: 10.1097/CCM.0000000000002816

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study : Prognosis of COVID-19 elderly critically ill patients in the ICU.

Authors:  Martin Dres; David Hajage; Said Lebbah; Antoine Kimmoun; Tai Pham; Gaëtan Béduneau; Alain Combes; Alain Mercat; Bertrand Guidet; Alexandre Demoule; Matthieu Schmidt
Journal:  Ann Intensive Care       Date:  2021-05-14       Impact factor: 6.925

2.  Right Ventricular Function in Acute Respiratory Distress Syndrome: Impact on Outcome, Respiratory Strategy and Use of Veno-Venous Extracorporeal Membrane Oxygenation.

Authors:  Matthieu Petit; Edouard Jullien; Antoine Vieillard-Baron
Journal:  Front Physiol       Date:  2022-01-14       Impact factor: 4.566

3.  Trend of extracorporeal membrane oxygenation support in patients with acute respiratory distress syndrome in South Korea.

Authors:  Tak Kyu Oh; In-Ae Song
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

4.  Inter-country variability over time in the mortality of mechanically ventilated patients.

Authors:  Oscar Peñuelas; Alfonso Muriel; Victor Abraira; Fernando Frutos-Vivar; Jordi Mancebo; Konstantinos Raymondos; Bin Du; Arnaud W Thille; Fernando Ríos; Marco González; Lorenzo Del-Sorbo; Niall D Ferguson; Maria Del Carmen Marín; Bruno Valle Pinheiro; Marco Antonio Soares; Nicolas Nin; Salvatore M Maggiore; Andrew Bersten; Pravin Amin; Nahit Cakar; Gee Young Suh; Fekri Abroug; Manuel Jibaja; Dimitros Matamis; Amine Ali Zeggwagh; Yuda Sutherasan; Antonio Anzueto; Andrés Esteban
Journal:  Intensive Care Med       Date:  2020-01-07       Impact factor: 41.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.